Peramivir

Records for this ingredient, by country (identity only).

ATC J05AH · 5 markets · 8 records

Peramivir 5 markets · 8 records Forms
Filters
MarketAU 2TW 2JP 2CA 1

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 10 mg/mL per mL / per unit basis not statedinjectionRAPIVAB peramivir 200 mg / 20 mL concentrate for intravenous infusion glass vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Rapivab ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 300 mg/60 mLinjectionラピアクタ点滴静注液バッグ300mg
  • 150 mg/15 mLinjectionラピアクタ点滴静注液バイアル150mg

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 10 mg per mL / per unit basis not statedliquidRapivab

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.